We report a case of amelanotic acral melanoma in a 42-year-old Chinese woman. Ten months previously the patient found a 2-cm asymmetric erythematous macular plaque on her left sole. The lesion was diagnosed as verruca plantaris by every physician the patient consulted. One month ago, an enlarged lymph node was detected in the left groin, which biopsy reported as metastatic melanoma. Dermoscopy suggested verruca plantaris, and positron emission tomography (PET) revealed increased glucose metabolism in the macular plaque. Finally, biopsy of the plaque revealed amelanotic melanoma. Misdiagnosis and diagnostic delay are usually associated with poorer patient outcomes. Awareness of atypical presentations of acral melanoma is thus important for decreasing misdiagnosis rates and improving patient outcomes.
We report a case of amelanotic acral melanoma in a 42-year-old Chinese woman. Ten months previously the patient found a 2-cm asymmetric erythematous macular plaque on her left sole. The lesion was diagnosed as verruca plantaris by every physician the patient consulted. One month ago, an enlarged lymph node was detected in the left groin, which biopsy reported as metastatic melanoma. Dermoscopy suggested verruca plantaris, and positron emission tomography (PET) revealed increased glucose metabolism in the macular plaque. Finally, biopsy of the plaque revealed amelanotic melanoma. Misdiagnosis and diagnostic delay are usually associated with poorer patient outcomes. Awareness of atypical presentations of acral melanoma is thus important for decreasing misdiagnosis rates and improving patient outcomes.
Amelanotic melanoma (AM) is a degenerative development of melanoma, composed of cells
derived from melanocytes but not forming melanin granules. It accounts for 2%
TROCARPORMIM 20% of melanoma lesions.[1] Early lesions are not typical, usually asymmetric pink nodules
with uniform color, unclear boundaries, and often slight pigmentation on the edge.
In later stages they can infiltrate and grow as red plaques, granulomatous nodules,
or ulcers.[2] Clinical and
pathological diagnosis of AM is difficult, given its different clinical
presentations and the fact that it may mimic non-melanocytic lesions. Plantar
melanoma exhibits a higher misdiagnosis rate relative to other anatomical
sites.[3] Misdiagnosis and
delay in diagnosis are statistically associated with poorer patient outcomes.
Awareness of atypical presentations of acral melanoma is thus important for
decreasing misdiagnosis rates and improving patient outcomes.
CASE REPORT
A 42-year-old Chinese female, otherwise healthy, presented with a 10-month history of
an asymmetric 2 -3 cm erythematous macular papule on her left sole that had
increased in size with accompanying minor tenderness (Figure 1). In the previous 6 months the lesion had been diagnosed as
verruca plantaris by 5 dermatologists, all of whom had recommended liquid nitrogen
cryotherapy, which the patient had not done. She had used frequent corn plasters and
2 months previously had pared down the thick cuticles on the lesion’s surface. One
month previously, an enlarged lymph node was detected in her left groin which biopsy
in the local hospital reported as metastatic melanoma (Figure 2). She came to our outpatient department and underwent
dermoscopic examination of the lesion, which suggested verruca plantaris. For
further verification, a positron emission tomography(PET) scan was performed,
showing elevated glucose metabolism in the left groin and in the macular papule
(Figure 1). One week previously she was
admitted for further treatment. Physical examination revealed a 2 to 3cm pink
macular papule on the pressure points of the left sole, surrounded by a firm, horny
ring. Irregular pigmented spots measuring approximately 0.5cm were visible on the
edge of the ring, and the top of the nodule had been pared down, showing small black
dots representing dilated capillary loops (Figure
1). Full metastatic workup was performed, and PET scan was positive for
left inguinal lymph node involvement and negative for metastases to other lymph
nodes and organs. She was otherwise fit and well, had no significant medical
history, and was not on any regular medications. An excisional biopsy showed an AM
with Breslow thickness of 2 mm, dermal mitotic rate >1/mm2, Clark
level papillary dermis, and presence of brisk tumor-infiltrating lymphocytes. No
microsatellitosis, regression, angiolymphatic invasion, or neurotropism were
detected (Figure 2). On immunohistochemical
analysis, S100, HMB45, and Melan-A were positive and Ki67 was 40% positive (Figure 3). Cytogenetic examination was negative
for gene BARF V600E mutation. The case was diagnosed as metastatic amelanotic acral
melanoma clinical stage III and pathologic stage IIIC (T2aN1bM0). A re-excision with
a 2 cm margin showed no residual tumor, and complete lymph node dissection was
performed.
Figure 1
A: Lesion on the sole; C: Linear bleeding seen
on dermoscopy, with large areas of unstructured space; B and
D: PET scan showed elevated glucose metabolism in the macular
papule on the left sole
Figure 2
A and B: Histopathology: macular papule showed tumor cells
arranged as nests in dermo-epidermal junction and dermis, and no obvious
melanin was observed; C and D: histopathology: left
inguinal lymph nodes revealed dense infiltration of tumor cells with
rich melanin granules in cytoplasm (hematoxylin & eosin, A, x40; B,
x200 ; C, x40 ; D, x200)
Figure 3
A - Tumor cells positive for Melan-A; B - Tumor
cells positive for HMB-45; C - Tumor cells positive for
S-100; D - Tumor cells 40% positive for Ki67; (A, Melan-A
x100; B, HMB-45 x100, ; C, S-100 x100 ; D, Ki67 x40)
A: Lesion on the sole; C: Linear bleeding seen
on dermoscopy, with large areas of unstructured space; B and
D: PET scan showed elevated glucose metabolism in the macular
papule on the left soleA and B: Histopathology: macular papule showed tumor cells
arranged as nests in dermo-epidermal junction and dermis, and no obvious
melanin was observed; C and D: histopathology: left
inguinal lymph nodes revealed dense infiltration of tumor cells with
rich melanin granules in cytoplasm (hematoxylin & eosin, A, x40; B,
x200 ; C, x40 ; D, x200)A - Tumor cells positive for Melan-A; B - Tumor
cells positive for HMB-45; C - Tumor cells positive for
S-100; D - Tumor cells 40% positive for Ki67; (A, Melan-A
x100; B, HMB-45 x100, ; C, S-100 x100 ; D, Ki67 x40)
DISCUSSION
We present a case of stage IIIC metastatic AM that posed a diagnostic challenge
because of its clinical presentation. The patient had been in her local hospital
several times, and the lesion had been diagnosed as verruca plantaris every time.
Until the enlarged lymph node biopsy showed metastatic melanoma, the attending
physicians were still in doubt whether the nodule was the primary lesion, due to its
verruca plantaris appearance and the fact that dermoscopy of the lesion also
suggested verruca plantaris. Biopsy of the nodule finally solved the riddle, showing
that it was a malignant melanoma. Misdiagnosis and diagnostic delay were most
certainly associated with worse outcome for the patient. Although the patient did
not hold the local hospital responsible for the misdiagnosis, the case called
attention to the need for greater vigilance in the presence of irregular
pigmentation on the palmoplantar boundaries, where malignant melanoma should be
considered. An important clue for avoiding misdiagnosis is that there is small
irregular pigmentation on the edge of the nodule that can easily be mistaken for
subcutaneous hemorrhage after incision, and biopsy is needed for differential
diagnosis. Biopsy of the pigmentation showed tumor cells arranged in nests
containing large amounts of melanin granules. It is also worth noting that
amelanotic acral melanoma can be clinically and dermoscopically
featureless.[4] Awareness
that amelanotic variants of acral melanoma can mimic the morphology of benign
hyperkeratotic dermatoses may increase the rate of correct diagnosis and improve
patient outcome.
Authors: Nancy E Thomas; Anne Kricker; Weston T Waxweiler; Patrick M Dillon; Klaus J Busman; Lynn From; Pamela A Groben; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Loraine D Marrett; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Terence Dwyer; Alison Venn; Peter A Kanetsky; Irene Orlow; Susan Paine; David W Ollila; Anne S Reiner; Li Luo; Honglin Hao; Jill S Frank; Colin B Begg; Marianne Berwick Journal: JAMA Dermatol Date: 2014-12 Impact factor: 10.282